MTSLead source
SITUATION DETECTED: Demis Hassabis’ Isomorphic Labs is in talks to raise $5 billion at a valuation of $50 billion to continue its AI-driven drug discovery work, per Bloomberg.Read original on X
StoryFirst seen
Isomorphic Labs in talks to raise $5 billion at $50 billion valuation
The AI drug discovery company's funding talks, reported by Bloomberg, would value it at $50 billion to continue its work.
Archived Updated
Everything it touches
0 names 1 voices 1 source posts
The story’s neighborhood
NAMESVOICESPOSTS
Explore the graph, or choose a connection below.
Follow the evidence
The source posts
This brief comes from Tech Twitter’s edited headlines. The posts below are the sources grouped with the story; statements in them belong to their authors.
How the headline evolved
Isomorphic Labs in talks to raise $5 billion at $50 billion valuation
Isomorphic Labs in talks to raise $5 billion at $50 billion valuation
Isomorphic Labs in talks to raise $5 billion at $50 billion valuation